Megadose CD34+ Selected Progenitor Cells

CD34+ selected progenitor cells · The University of Texas MD Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Megadose CD34+ Selected Progenitor Cells, covering 2012-08-07 to 2012-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases [Phase 2]

See pricing